Matches in Nanopublications for { ?s ?p "[ASXL1 haploinsufficiency is associated with a myelofibrosis phenotype in the context of other known and unknown lesions, and disruption of ASXL1 function may contribute to the disease pathogenesis of myelofibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP652977.RA6OHUDzHPGBl43wv_A4TOIj-PZ2SMDY-67YZXq6D3_tU130_assertion description "[ASXL1 haploinsufficiency is associated with a myelofibrosis phenotype in the context of other known and unknown lesions, and disruption of ASXL1 function may contribute to the disease pathogenesis of myelofibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP652977.RA6OHUDzHPGBl43wv_A4TOIj-PZ2SMDY-67YZXq6D3_tU130_provenance.
- NP978387.RAYf2K0TldO1UBkNV5I7gaTh7Fyicp6y3wkd97lypIGb0130_assertion description "[ASXL1 haploinsufficiency is associated with a myelofibrosis phenotype in the context of other known and unknown lesions, and disruption of ASXL1 function may contribute to the disease pathogenesis of myelofibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978387.RAYf2K0TldO1UBkNV5I7gaTh7Fyicp6y3wkd97lypIGb0130_provenance.
- NP905685.RAcRcCuLf2GUqUoiSAby3V3RtADbulgS9SZuOvHuuvW9M130_assertion description "[ASXL1 haploinsufficiency is associated with a myelofibrosis phenotype in the context of other known and unknown lesions, and disruption of ASXL1 function may contribute to the disease pathogenesis of myelofibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP905685.RAcRcCuLf2GUqUoiSAby3V3RtADbulgS9SZuOvHuuvW9M130_provenance.
- NP978543.RAAl0pg7JgIfEngO61Otr_xivP5uPHplLx7lMTXi70XVQ130_assertion description "[ASXL1 haploinsufficiency is associated with a myelofibrosis phenotype in the context of other known and unknown lesions, and disruption of ASXL1 function may contribute to the disease pathogenesis of myelofibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978543.RAAl0pg7JgIfEngO61Otr_xivP5uPHplLx7lMTXi70XVQ130_provenance.
- assertion description "[ASXL1 haploinsufficiency is associated with a myelofibrosis phenotype in the context of other known and unknown lesions, and disruption of ASXL1 function may contribute to the disease pathogenesis of myelofibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[ASXL1 haploinsufficiency is associated with a myelofibrosis phenotype in the context of other known and unknown lesions, and disruption of ASXL1 function may contribute to the disease pathogenesis of myelofibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP905683.RArvVOHIaNw0KiHz6Ip9ALxhlxan5_UdCQiBcLkXafE5Y130_assertion description "[ASXL1 haploinsufficiency is associated with a myelofibrosis phenotype in the context of other known and unknown lesions, and disruption of ASXL1 function may contribute to the disease pathogenesis of myelofibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP905683.RArvVOHIaNw0KiHz6Ip9ALxhlxan5_UdCQiBcLkXafE5Y130_provenance.